Condition

Chronic Rhinosinusitis With Nasal Polyps

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 14 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials14
Recruiting3
Common interventions25
Lead sponsors shown12
Advertisement

Clinical trials

14 shown
Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial AsthmaNCT05708300 · 2024-02-23
RECRUITING
Real Life Study of Biologicals in Patients With Severe CRSwNPNCT05938972 · 2022-03-01
RECRUITING
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal PolypsNCT05009758 · 2021-09-01
RECRUITING
Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe AsthmaNCT06740045 · 2025-01-01
NOT_YET_RECRUITING
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With PolypsNCT06556264 · 2024-08-01
UNKNOWN
Proof of Concept of Remote Management of Chronic Inflammatory Airway Diseases for Patient EmpowermentNCT06217419 · 2024-02-01
UNKNOWN
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic AsthmaNCT06069310 · 2023-09-01
ACTIVE_NOT_RECRUITING
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab TreatmentNCT05642806 · 2023-07-01
UNKNOWN
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal PolypsNCT05942222 · 2023-04-27
ACTIVE_NOT_RECRUITING
Adherence in Global Airways - Steroid Intake and Effects on Chronic RhinosinosinutisNCT05843019 · 2023-04-12
UNKNOWN
Adherence in Global AirwaysNCT05553951 · 2022-10-01
UNKNOWN
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsNCT04998604 · 2021-09-27
COMPLETED
Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)NCT04823585 · 2021-08-12
COMPLETED
Tissue Immune Interaction in Nasal PolyposisNCT04628442 · 2020-11-10
COMPLETED

Common interventions

Trial status mix

UNKNOWN5
COMPLETED3
RECRUITING3
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING1

Phase mix

PHASE45
NA3
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.